Viewing StudyNCT06066359



Ignite Creation Date: 2024-05-06 @ 7:35 PM
Last Modification Date: 2024-10-26 @ 3:10 PM
Study NCT ID: NCT06066359
Status: RECRUITING
Last Update Posted: 2024-06-04
First Post: 2023-09-27

Brief Title: Phase III Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCRIL-15 Cell Receptor for RelapsedRefractory Multiple Myeloma
Sponsor:
Organization: MD Anderson Cancer Center